[1]
M. Szkultecka-Debek, “An analysis of potential costs of adverse events based on Drug Programs in Poland. Pulmonology focus”, Curr. Issues Pharm. Med. Sci., vol. 27, no. 1, pp. 32–36, May 2014, doi: 10.2478/cipms-2014-0009.